Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Precose, Glucobay, Prandase, Glyset
Acarbose is an oral alpha-glucosidase inhibitor used for managing type 2 diabetes. It works by slowing the digestion and absorption of carbohydrates in the small intestine, thereby reducing the postprandial rise in blood glucose levels. It belongs to the class of antidiabetic agents.
For managing type 2 diabetes by slowing carbohydrate absorption and reducing postprandial hyperglycemia.
Outcome:
Decreased digoxin absorption
Mechanism:
Acarbose can interfere with digoxin absorption.
Outcome:
Decreased acarbose efficacy
Mechanism:
Amylase can break down acarbose.
Outcome:
Potential for reduced absorption of certain vitamins
Mechanism:
Acarbose may affect nutrient absorption.
Most likely new formulation: sustained-release acarbose (Year 2025, 60% confidence)
Based on current usage trends and emerging therapies, there is a 75% likelihood of acarbose remaining a relevant treatment option for type 2 diabetes in the next 5 years.
Alpha-glucosidase Inhibitor, Antidiabetic Agent
Pseudotetrasaccharide